4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-004762
CVP,Strategy/Corp Development sold 6,725 shares at $83.09 ($558,801)
- CVP,Strategy/Corp Development acquired 6,725 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BOBO DONALD E JR · CVP,Strategy/Corp Development
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,725 | $35.20 | $236,698 | 69,548.69 | D |
| 2023-04-06 | Sale : show line 2 in the form 10b5-1 | −6,725 | $83.09 | $558,801 | 62,823.69 | D |
| Open-market sales · 6,725 sh · avg $83.09 · $558,801 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-04-06 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −6,725 | $35.20 | 2023-05-11 | 6,725 | 0 | D |
Loading xslF345X04/doc4.xml…